All In MedTech

Device Trial Radar · NCT02868736

Clinical Validation of CD Diagnostics Synovasure PJI ELISA Test and Synovasure PJI Lateral Flow Test for Detection of Periprosthetic Joint Infection in Synovial Fluid

Last checked: Nov 20, 2026Latest source record: Aug 16, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

3,000

Planned (sponsor's estimate)

Start

Jul 2016

Primary completion

Apr 2017

Study completion May 2017

Sponsor

Lead sponsor
CD DiagnosticsNot on our public-company list
Sponsor type
Industry
First posted
Aug 16, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

* To demonstrate the tests' performance when compared to the detection of PJI using the Musculoskeletal Infection Society (MSIS) criteria-based definition of PJI for diagnosing PJI.1 This criteria-based definition of PJI places emphasis on culture techniques that identify pathogens, but also provides for minor criteria that can be used to diagnose PJI; * To calculate the tests' clinical sensitivity, clinical specificity, positive predictive value (PPV), and negative predictive value (NPV).

Conditions

  • Periprosthetic Joint Infection

Interventions

  • Synovasure PJI Lateral Flow test and Synovasure PJI ELISA TestDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of laboratory results and physical findings required to diagnose PJITime frame: Outcome is measured at time of aspiration and again at time of revision surgery.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.